Virtual screening in drug discovery
|
|
- Thomasina Bruce
- 5 years ago
- Views:
Transcription
1 Virtual screening in drug discovery Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University
2 Drug development workflow Vistoli G., et al., Drug Discovery Today, 2008, 13,
3 The challenge Chemical space Biological space ~10 36 drug-like compounds (1) ~ human proteins {2} Drug discovery (1) Polishchuk, P. G.; Madzhidov, T. I.; Varnek, A., J Comput Aided Mol Des 2013, 27, (2) 3
4 Vastness of chemical space real datasets ~ 110 M compounds ~ 75 M compounds Commercial ~ 88 M compounds Free virtually enumerated dataset GDB B compounds = 1.66x10 11 estimated size of drug-like chemical space compounds 4
5 Screening High-throughput screening up to 10 6 of compounds can be tested expensive not all targets are suitable for HTS Virtual screening up to 10 9 of compounds can be tested 5
6 Virtual screening methods 3D structure of target unknown known Ligand-based Structure-based actives known actives and inactives known 1 or more actives few or more actives Similarity search Pharmacophore search Machine learning (QSAR) Docking capacity: ~ 10 9 ~ 10 7 ~ 10 7 ~ 10 6 complexity increases 6
7 Similarity search 3D structure of target unknown known Ligand-based Structure-based actives known actives and inactives known 1 or more actives few or more actives Similarity search Pharmacophore search Machine learning (QSAR) Docking capacity: ~ 10 9 ~ 10 7 ~ 10 7 ~ 10 6 complexity increases 7
8 Similarity principle Similar compounds have similar properties morphine codeine Rank and select similar compounds reference compound decrease similarity 8
9 Are they similar? morphine codeine S-thalidomide R-thalidomide tirofibane tirofibane ethyl ester eptifibatide
10 Similarity search Structure representation structural keys fingerprints Similarity measure Tanimoto Dice Euclidian morphine codeine Tanimoto Dice MACCS Atom pairs Morgan (ECFP4-like) Morgan (FCFP4-like) calculated with RDKit Similarity search output depends on descriptors and similarity measure selected 10
11 Similarity search: example agonists of CCR compounds 100 FCFP4 compounds IC 50 = 17 μm purchased & tested IC 50 = 5.8 μm IC 50 = 14.1 μm Kellenberger, E., et al., Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening. Journal of Medicinal Chemistry 2007, 50,
12 Similarity search: conclusion + Little information is required to start searching + Different chemotypes can be retrieved + Ultra fast screening + Scaffold hopping - Hits will share common substructures with reference structures that may reduce their patentability - Results depend on chosen descriptors and similarity measure - Chemical similarity is not always followed by biological one 12
13 Pharmacophore search 3D structure of target unknown known Ligand-based Structure-based actives known actives and inactives known 1 or more actives few or more actives Similarity search Pharmacophore search Machine learning (QSAR) Docking capacity: ~ 10 9 ~ 10 7 ~ 10 7 ~ 10 6 complexity increases 13
14 Pharmacophore definition A pharmacophore is the ensemble of steric and electronic features that is necessary to ensure the optimal supramolecular interaction with a specific biological target structure and to trigger (or block) its biological response. Annu. Rep. Med. Chem. 1998, 33,
15 Early pharmacophore hypotheses 6.7 Å 6.9 Å 2.3 Å 2.4 Å π π interaction ionic interaction π π interaction X ionic interaction A H-bond B H-bond (R)-(-) Epinephrine (Adrenalin) (S)-(+) Epinephrine 15
16 Atom- and pharmacophore-based alignment Methotrexate Dihydrofolate Hydrogen bonding patterns Atom-based alignment Pharmacophore alignment 16
17 Feature-based pharmacophore models Features: Electrostatic interactions, H-bonding, aromatic interactions, hydrophobic regions, coordination to metal ions... Pharmacophore features H-bond donor H-bond acceptor Positive ionizable Negative ionizable Hydrophobic Aromatic ring 17
18 Feature-based pharmacophores (LigandScout) PDB code: 2VDM H-bonds formed by the ligand Hydrophobic interaction Pharmacophore features H-bond donor H-bond acceptor Positive ionizable Negative ionizable Hydrophobic 18
19 Typical ligand-based pharmacophore modeling workflow Clean structures of ligands Generate conformers Assign pharmacophore features Find common pharmacophores Score pharmacophore hypotheses Validation of pharmacophore models 19
20 Shared consensus pharmacophore (LigandScout) 2IVV 2IVU RET Kinase Inhibitors 20
21 Pharmacophore examples Shared model on 83 antagonists of fibrinogen receptor Pharmacophore models obtained for clusters of compounds Precision: 0.72 Recall: 0.77 Precision: 0.77 Recall: 0.27 Precision: 0.67 Recall: 0.29 Precision: 0.90 Recall: 0.04 Polishchuk, P. G. et al., Journal of Medicinal Chemistry 2015, 58,
22 Pharmacophore example Ala scan NMR Urotensin II - ETPDc[CFWKYCV] potent vasoconstrictor IC 50 = 400 nm 500 hits Flohr S. et al., J. Med. Chem., 2002, 45 (9), pp
23 Pharmacophores: conclusion + Universal representation of binding pattern + Qualitative output + Very fast screening + Scaffold hopping - Structure-based models can be very specific - Ligand-based models depend on conformational sampling 23
24 Machine learning (QSAR) 3D structure of target unknown known Ligand-based Structure-based actives known actives and inactives known 1 or more actives few or more actives Similarity search Pharmacophore search Machine learning (QSAR) Docking capacity: ~ 10 9 ~ 10 7 ~ 10 7 ~ 10 6 complexity increases 24
25 Modeling of compounds properties Activity = F(structure) X 1 X 2 X 3 X 4 X 5 X 6 X N Activity = M(E(structure)) M mapping function E encoding function 25
26 QSAR modeling workflow Structure Descriptors (features) End-point values Model X 1 X 2 X 3 X 4 X 5 X 6 X N Y Encoding (represent structure with numerical features) Mapping (machine learning) 26
27 Overall QSAR workflow Input data Preprocessing Feature engineering Model training Model validation Interpretation x ' i x i j x z j Bioassays Databases Data normalization & curation Feature extraction Feature selection Feature combination Classification Regression Clustering Cross-validation Bootstrap Test set Applicability Domain OECD principles for the validation, for regulatory purposes, of (Q)SAR models 1) a defined endpoint 2) an unambiguous algorithm 3) a defined domain of applicability 4) appropriate measures of goodness-of fit, robustness and predictivity 5) a mechanistic interpretation, if possible 27
28 QSAR model building plant growth inhibition activity of phenoxyacetic acids Hansch equation 1/C = 4.08π 2.14π σ π = logp X logp H σ - Hammet constant Free-Wilson models Inhibition activity of compounds against Staphylococcus aureus R is H or CH 3 ; X is Br, Cl, NO 2 and Y is NO 2, NH 2, NHC(=O)CH 3 Act = 75R H 112R CH3 + 84X Cl 16X Br 26X NO Y NH2 + 18Y NHC(=O)CH3 218Y NO2
29 QSAR: example Antimalarial activity 7 hits, EC 50 < 2μM EC 50 = 95 nm Zhang L. et al., J. Chem. Inf. Model., 2013, 53 (2), pp
30 QSAR: conclusion + Qualitative and quantitative output + May work for compounds having different mechanisms of action + Fast screening - Very demanding to the quality of input data - Applicability limited by the training set structures - Hard to encode stereochemistry 30
31 Molecular docking 3D structure of target unknown known Ligand-based Structure-based actives known actives and inactives known 1 or more actives few or more actives Similarity search Pharmacophore search Machine learning (QSAR) Docking capacity: ~ 10 9 ~ 10 7 ~ 10 7 ~ 10 6 complexity increases 31
32 Docking is an in silico tool which predicts Bioorganic & Medicinal Chemistry, 20 (12), 2012, Pose a possible relative orientation of a ligand and a receptor as well as conformation of a ligand and a receptor when they are form complex Score the strength of binding of the ligand and the receptor.
33 Why docking is a hard task Complex 3D jigsaw puzzle Conformational flexibility many degrees of freedom Mutual adaptation ( induced fit ) Solvation in aqueous media Complexity of thermodynamic contribution No easy route to evaluation of ΔG Simplification and heuristic approaches are necessary At its simplest level, this is a problem of subtraction of large numbers, inaccurately calculated, to arrive at a small number. (Leach A.R., Shoichet B.K., Peishoff C.E.. J. Med. Chem. 2006, 49, ) 33
34 Sampling and scoring Protein-ligand docking software consists of two main components which work together: 1. Search algorithm (sampling) - generates a large number of poses of a molecule in the binding site. 2. Scoring function - calculates a score or binding affinity for a particular pose 34
35 Search algorithms (sampling) Ligand Rigid Receptor Rigid Fast & Simple Flexible Rigid Flexible Flexible Slow & Complex 35
36 Classes of scoring function Forcefield-based Based on terms from molecular mechanics forcefields GoldScore, DOCK, AutoDock Empirical Parameterised against experimental binding affinities ChemScore, PLP, Glide SP/XP Knowledge-based potentials Based on statistical analysis of observed pairwise distributions PMF, DrugScore, ASP 36
37 Docking quality assessment Energy reproducibility HIV-1 protease Test set size = 800 molecules r < 0.55 R. Wang J. Chem. Inf. Comput. Sci., 2004, 44 (6), pp
38 Docking quality assessment Antagonists of α IIb β 3 Activity, pic 50 PLANTS S4MPLE Krysko, A.A., et al., Bioorganic & Medicinal Chemistry Letters, 2016, 26,
39 Validation Self-docking reproducibility of a pose Docking of a set of ligands with known affinity reproducibility of affinity 39
40 Molecular docking: example β 2 -adrenoreceptor ligands ZINC compounds DOCK diversity selection 500 compounds 25 compounds K i < 4μM 6 hits binding mode comparing to carazolol (X-ray ligand) K i = 9 nm Kolb, P. et al., PNAS of the United States of America, 2009, 106,
41 Molecular docking: conclusion + Relatively fast + Determine binding poses & energy + Good in ranking ligands for virtual screening - Low accuracy of binding energy estimation - Require knowledge about binding site 41
42 Consensus virtual screening 2D Pharmacophore QSAR (ISIDA, SIRMS) 3D Pharmacophore (LigandScout) Field-similarity (Cresset) Docking (MOE, PLANTS, FlexX) Shape-similarity (ROCS) 42
43 Virtual screening BioinfoDB (curated ZINC) ~ compounds 2D pharmacophore model 16Å bonds (C sp3 C sp3 ) 210 compounds 3D pharmacophore (ligand-based) QSAR models 0 compounds 0 compounds No hits commercial libraries contain just a few number of zwitterionic compounds Polishchuk, P. G. et al., Journal of Medicinal Chemistry 2015, 58,
44 Virtual screening of focused library 3D pharmacophore models ensemble QSAR 6930 (24066 stereisomers) 2064 Docking Shape- and field-based ADME/Tox, PASS, synthetic feasibility Polishchuk, P. G. et al., Journal of Medicinal Chemistry 2015, 58,
45 Biological activity of synthesized compounds Affinity for αiibβ3 Anti-aggregation Tirofiban Polishchuk, P. G. et al., Journal of Medicinal Chemistry 2015, 58,
46 Examples of CADD contribution to drug development Aliskiren Target Indication Role of CADD Renin Hypertension Structure-based optimization of the size of the hydrophobic group filling the large S1-S3 cavity. The methoxyalkoxy sidechain of the inhibitor is essential for strong binding Nilotinib Abl-kinase Chronic myeloid leukemia Replacement of imatinib N-methyl piperazine by a methylindole that optimally fits a subpocket of the kinase inactive structure Rilpivirine HIV reverse transcriptase AIDS Adaptation to the allosteric nonnucleoside binding site and targeting of the conserved Trp299 Rognan D., Pharmacology & Therapeutics 2017, 174,
47 PhD topic Computationally guided de novo design of compounds with desired properties Development of a platform for multi-objective optimization of compound properties (ADME, activity, selectivity, etc) based on computational models (QSAR, pharmacophore, docking, etc) Input structure(s) to be optimized QSAR model(s), docking Estimation of atoms/fragments contributions based on QSAR models, docking Transformation of structural motifs with negative influence on the target property Pharmacophore model(s), etc Property prediction Decision module: Is compound satisfy optimal criteria (profile)? Yes Selection, synthesis and testing No
48 Thank you for your attention 48
Structural biology and drug design: An overview
Structural biology and drug design: An overview livier Taboureau Assitant professor Chemoinformatics group-cbs-dtu otab@cbs.dtu.dk Drug discovery Drug and drug design A drug is a key molecule involved
More informationComputational chemical biology to address non-traditional drug targets. John Karanicolas
Computational chemical biology to address non-traditional drug targets John Karanicolas Our computational toolbox Structure-based approaches Ligand-based approaches Detailed MD simulations 2D fingerprints
More informationIntroduction. OntoChem
Introduction ntochem Providing drug discovery knowledge & small molecules... Supporting the task of medicinal chemistry Allows selecting best possible small molecule starting point From target to leads
More informationDr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre
Dr. Sander B. Nabuurs Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre The road to new drugs. How to find new hits? High Throughput
More informationChemical library design
Chemical library design Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University pavlo.polishchuk@upol.cz Drug development workflow Vistoli G., et al., Drug Discovery Today,
More informationDocking. GBCB 5874: Problem Solving in GBCB
Docking Benzamidine Docking to Trypsin Relationship to Drug Design Ligand-based design QSAR Pharmacophore modeling Can be done without 3-D structure of protein Receptor/Structure-based design Molecular
More informationChemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller
Chemogenomic: Approaches to Rational Drug Design Jonas Skjødt Møller Chemogenomic Chemistry Biology Chemical biology Medical chemistry Chemical genetics Chemoinformatics Bioinformatics Chemoproteomics
More informationUsing Phase for Pharmacophore Modelling. 5th European Life Science Bootcamp March, 2017
Using Phase for Pharmacophore Modelling 5th European Life Science Bootcamp March, 2017 Phase: Our Pharmacohore generation tool Significant improvements to Phase methods in 2016 New highly interactive interface
More informationBiologically Relevant Molecular Comparisons. Mark Mackey
Biologically Relevant Molecular Comparisons Mark Mackey Agenda > Cresset Technology > Cresset Products > FieldStere > FieldScreen > FieldAlign > FieldTemplater > Cresset and Knime About Cresset > Specialist
More informationHit Finding and Optimization Using BLAZE & FORGE
Hit Finding and Optimization Using BLAZE & FORGE Kevin Cusack,* Maria Argiriadi, Eric Breinlinger, Jeremy Edmunds, Michael Hoemann, Michael Friedman, Sami Osman, Raymond Huntley, Thomas Vargo AbbVie, Immunology
More informationStructure-Activity Modeling - QSAR. Uwe Koch
Structure-Activity Modeling - QSAR Uwe Koch QSAR Assumption: QSAR attempts to quantify the relationship between activity and molecular strcucture by correlating descriptors with properties Biological activity
More informationIgnasi Belda, PhD CEO. HPC Advisory Council Spain Conference 2015
Ignasi Belda, PhD CEO HPC Advisory Council Spain Conference 2015 Business lines Molecular Modeling Services We carry out computational chemistry projects using our selfdeveloped and third party technologies
More informationIn silico pharmacology for drug discovery
In silico pharmacology for drug discovery In silico drug design In silico methods can contribute to drug targets identification through application of bionformatics tools. Currently, the application of
More informationMM-GBSA for Calculating Binding Affinity A rank-ordering study for the lead optimization of Fxa and COX-2 inhibitors
MM-GBSA for Calculating Binding Affinity A rank-ordering study for the lead optimization of Fxa and COX-2 inhibitors Thomas Steinbrecher Senior Application Scientist Typical Docking Workflow Databases
More informationSimilarity Search. Uwe Koch
Similarity Search Uwe Koch Similarity Search The similar property principle: strurally similar molecules tend to have similar properties. However, structure property discontinuities occur frequently. Relevance
More informationVirtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME
Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME Iván Solt Solutions for Cheminformatics Drug Discovery Strategies for known targets High-Throughput Screening (HTS) Cells
More informationStructure based drug design and LIE models for GPCRs
Structure based drug design and LIE models for GPCRs Peter Kolb kolb@docking.org Shoichet Lab ACS 237 th National Meeting, March 24, 2009 p.1/26 [Acknowledgements] Brian Shoichet John Irwin Mike Keiser
More informationProtein Structure Prediction and Protein-Ligand Docking
Protein Structure Prediction and Protein-Ligand Docking Björn Wallner bjornw@ifm.liu.se Jan. 24, 2014 Todays topics Protein Folding Intro Protein structure prediction How can we predict the structure of
More informationUsing AutoDock for Virtual Screening
Using AutoDock for Virtual Screening CUHK Croucher ASI Workshop 2011 Stefano Forli, PhD Prof. Arthur J. Olson, Ph.D Molecular Graphics Lab Screening and Virtual Screening The ultimate tool for identifying
More informationDe Novo molecular design with Deep Reinforcement Learning
De Novo molecular design with Deep Reinforcement Learning @olexandr Olexandr Isayev, Ph.D. University of North Carolina at Chapel Hill olexandr@unc.edu http://olexandrisayev.com About me Ph.D. in Chemistry
More informationThe PhilOEsophy. There are only two fundamental molecular descriptors
The PhilOEsophy There are only two fundamental molecular descriptors Where can we use shape? Virtual screening More effective than 2D Lead-hopping Shape analogues are not graph analogues Molecular alignment
More informationProgress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery
21 th /June/2018@CUGM Progress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery Kaz Ikeda, Ph.D. Keio University Self Introduction Keio University, Tokyo, Japan (Established
More informationRetrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a
Retrieving hits through in silico screening and expert assessment M.. Drwal a,b and R. Griffith a a: School of Medical Sciences/Pharmacology, USW, Sydney, Australia b: Charité Berlin, Germany Abstract:
More informationInterpretation of QSAR models
BIGCHEM, online lecture, 7 Febuary 2018 Interpretation of QSAR models Pavel Polishchuk Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacky University pavlo.polishchuk@upol.cz
More informationSoftwares for Molecular Docking. Lokesh P. Tripathi NCBS 17 December 2007
Softwares for Molecular Docking Lokesh P. Tripathi NCBS 17 December 2007 Molecular Docking Attempt to predict structures of an intermolecular complex between two or more molecules Receptor-ligand (or drug)
More informationKd = koff/kon = [R][L]/[RL]
Taller de docking y cribado virtual: Uso de herramientas computacionales en el diseño de fármacos Docking program GLIDE El programa de docking GLIDE Sonsoles Martín-Santamaría Shrödinger is a scientific
More informationVirtual Screening: How Are We Doing?
Virtual Screening: How Are We Doing? Mark E. Snow, James Dunbar, Lakshmi Narasimhan, Jack A. Bikker, Dan Ortwine, Christopher Whitehead, Yiannis Kaznessis, Dave Moreland, Christine Humblet Pfizer Global
More informationA Tiered Screen Protocol for the Discovery of Structurally Diverse HIV Integrase Inhibitors
A Tiered Screen Protocol for the Discovery of Structurally Diverse HIV Integrase Inhibitors Rajarshi Guha, Debojyoti Dutta, Ting Chen and David J. Wild School of Informatics Indiana University and Dept.
More informationIntroduction to Chemoinformatics and Drug Discovery
Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013 The Chemical Space There are atoms and space. Everything else is opinion. Democritus (ca.
More informationWhat is Protein-Ligand Docking?
MOLECULAR DOCKING Definition: What is Protein-Ligand Docking? Computationally predict the structures of protein-ligand complexes from their conformations and orientations. The orientation that maximizes
More informationData Quality Issues That Can Impact Drug Discovery
Data Quality Issues That Can Impact Drug Discovery Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc, Sunnyvale, CA. 3 Royal Society of Chemistry,
More informationComputational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007
Computational Chemistry in Drug Design Xavier Fradera Barcelona, 17/4/2007 verview Introduction and background Drug Design Cycle Computational methods Chemoinformatics Ligand Based Methods Structure Based
More informationExploring the black box: structural and functional interpretation of QSAR models.
EMBL-EBI Industry workshop: In Silico ADMET prediction 4-5 December 2014, Hinxton, UK Exploring the black box: structural and functional interpretation of QSAR models. (Automatic exploration of datasets
More informationPlan. Day 2: Exercise on MHC molecules.
Plan Day 1: What is Chemoinformatics and Drug Design? Methods and Algorithms used in Chemoinformatics including SVM. Cross validation and sequence encoding Example and exercise with herg potassium channel:
More informationLigandScout. Automated Structure-Based Pharmacophore Model Generation. Gerhard Wolber* and Thierry Langer
LigandScout Automated Structure-Based Pharmacophore Model Generation Gerhard Wolber* and Thierry Langer * E-Mail: wolber@inteligand.com Pharmacophores from LigandScout Pharmacophores & the Protein Data
More informationLigand-receptor interactions
University of Silesia, Katowice, Poland 11 22 March 2013 Ligand-receptor interactions Dr. Pavel Polishchuk A.V. Bogatsky Physico-Chemical Institute of National Academy of Sciences of Ukraine Odessa, Ukraine
More informationDesign and Synthesis of the Comprehensive Fragment Library
YOUR INNOVATIVE CHEMISTRY PARTNER IN DRUG DISCOVERY Design and Synthesis of the Comprehensive Fragment Library A 3D Enabled Library for Medicinal Chemistry Discovery Warren S Wade 1, Kuei-Lin Chang 1,
More informationBioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA
Pharmacophore Model Development for the Identification of Novel Acetylcholinesterase Inhibitors Edwin Kamau Dept Chem & Biochem Kennesa State Uni ersit Kennesa GA 30144 Dept. Chem. & Biochem. Kennesaw
More informationCheminformatics analysis and learning in a data pipelining environment
Molecular Diversity (2006) 10: 283 299 DOI: 10.1007/s11030-006-9041-5 c Springer 2006 Review Cheminformatics analysis and learning in a data pipelining environment Moises Hassan 1,, Robert D. Brown 1,
More informationStructural Bioinformatics (C3210) Molecular Docking
Structural Bioinformatics (C3210) Molecular Docking Molecular Recognition, Molecular Docking Molecular recognition is the ability of biomolecules to recognize other biomolecules and selectively interact
More informationChemoinformatics and information management. Peter Willett, University of Sheffield, UK
Chemoinformatics and information management Peter Willett, University of Sheffield, UK verview What is chemoinformatics and why is it necessary Managing structural information Typical facilities in chemoinformatics
More informationQSAR/QSPR modeling. Quantitative Structure-Activity Relationships Quantitative Structure-Property-Relationships
Quantitative Structure-Activity Relationships Quantitative Structure-Property-Relationships QSAR/QSPR modeling Alexandre Varnek Faculté de Chimie, ULP, Strasbourg, FRANCE QSAR/QSPR models Development Validation
More informationIn Silico Investigation of Off-Target Effects
PHARMA & LIFE SCIENCES WHITEPAPER In Silico Investigation of Off-Target Effects STREAMLINING IN SILICO PROFILING In silico techniques require exhaustive data and sophisticated, well-structured informatics
More informationQSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression
APPLICATION NOTE QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression GAINING EFFICIENCY IN QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS ErbB1 kinase is the cell-surface receptor
More informationDevelopment of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining
Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining Samer Haidar 1, Zouhair Bouaziz 2, Christelle Marminon 2, Tiomo Laitinen 3, Anti Poso
More informationProtein-Ligand Docking Evaluations
Introduction Protein-Ligand Docking Evaluations Protein-ligand docking: Given a protein and a ligand, determine the pose(s) and conformation(s) minimizing the total energy of the protein-ligand complex
More informationReceptor Based Drug Design (1)
Induced Fit Model For more than 100 years, the behaviour of enzymes had been explained by the "lock-and-key" mechanism developed by pioneering German chemist Emil Fischer. Fischer thought that the chemicals
More informationMolecular Dynamics Graphical Visualization 3-D QSAR Pharmacophore QSAR, COMBINE, Scoring Functions, Homology Modeling,..
3 Conformational Search Molecular Docking Simulate Annealing Ab Initio QM Molecular Dynamics Graphical Visualization 3-D QSAR Pharmacophore QSAR, COMBINE, Scoring Functions, Homology Modeling,.. Rino Ragno:
More informationCheminformatics platform for drug discovery application
EGI-InSPIRE Cheminformatics platform for drug discovery application Hsi-Kai, Wang Academic Sinica Grid Computing EGI User Forum, 13, April, 2011 1 Introduction to drug discovery Computing requirement of
More informationPlan. Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics.
Plan Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics. Exercise: Example and exercise with herg potassium channel: Use of
More informationAn Integrated Approach to in-silico
An Integrated Approach to in-silico Screening Joseph L. Durant Jr., Douglas. R. Henry, Maurizio Bronzetti, and David. A. Evans MDL Information Systems, Inc. 14600 Catalina St., San Leandro, CA 94577 Goals
More informationQuantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation
Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation Charles Blundell charles.blundell@c4xdiscovery.com www.c4xdiscovery.com Rigid: single
More informationDOCKING TUTORIAL. A. The docking Workflow
2 nd Strasbourg Summer School on Chemoinformatics VVF Obernai, France, 20-24 June 2010 E. Kellenberger DOCKING TUTORIAL A. The docking Workflow 1. Ligand preparation It consists in the standardization
More informationContents 1 Open-Source Tools, Techniques, and Data in Chemoinformatics
Contents 1 Open-Source Tools, Techniques, and Data in Chemoinformatics... 1 1.1 Chemoinformatics... 2 1.1.1 Open-Source Tools... 2 1.1.2 Introduction to Programming Languages... 3 1.2 Chemical Structure
More informationbcl::cheminfo Suite Enables Machine Learning-Based Drug Discovery Using GPUs Edward W. Lowe, Jr. Nils Woetzel May 17, 2012
bcl::cheminfo Suite Enables Machine Learning-Based Drug Discovery Using GPUs Edward W. Lowe, Jr. Nils Woetzel May 17, 2012 Outline Machine Learning Cheminformatics Framework QSPR logp QSAR mglur 5 CYP
More informationTargeting protein-protein interactions: A hot topic in drug discovery
Michal Kamenicky; Maria Bräuer; Katrin Volk; Kamil Ödner; Christian Klein; Norbert Müller Targeting protein-protein interactions: A hot topic in drug discovery 104 Biomedizin Innovativ patientinnenfokussierte,
More informationHigh Throughput In-Silico Screening Against Flexible Protein Receptors
John von Neumann Institute for Computing High Throughput In-Silico Screening Against Flexible Protein Receptors H. Sánchez, B. Fischer, H. Merlitz, W. Wenzel published in From Computational Biophysics
More informationBridging the Dimensions:
Bridging the Dimensions: Seamless Integration of 3D Structure-based Design and 2D Structure-activity Relationships to Guide Medicinal Chemistry ACS Spring National Meeting. COMP, March 13 th 2016 Marcus
More informationAuthor Index Volume
Perspectives in Drug Discovery and Design, 20: 289, 2000. KLUWER/ESCOM Author Index Volume 20 2000 Bradshaw,J., 1 Knegtel,R.M.A., 191 Rose,P.W., 209 Briem, H., 231 Kostka, T., 245 Kuhn, L.A., 171 Sadowski,
More informationMedicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design
Medicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design Bela Torok Department of Chemistry University of Massachusetts Boston Boston, MA 1 Computer Aided Drug Design - Introduction Development
More informationDispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses
Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc,
More informationCOMPARISON OF SIMILARITY METHOD TO IMPROVE RETRIEVAL PERFORMANCE FOR CHEMICAL DATA
http://www.ftsm.ukm.my/apjitm Asia-Pacific Journal of Information Technology and Multimedia Jurnal Teknologi Maklumat dan Multimedia Asia-Pasifik Vol. 7 No. 1, June 2018: 91-98 e-issn: 2289-2192 COMPARISON
More informationKNIME-based scoring functions in Muse 3.0. KNIME User Group Meeting 2013 Fabian Bös
KIME-based scoring functions in Muse 3.0 KIME User Group Meeting 2013 Fabian Bös Certara Mission: End-to-End Model-Based Drug Development Certara was formed by acquiring and integrating Tripos, Pharsight,
More informationBUDE. A General Purpose Molecular Docking Program Using OpenCL. Richard B Sessions
BUDE A General Purpose Molecular Docking Program Using OpenCL Richard B Sessions 1 The molecular docking problem receptor ligand Proteins typically O(1000) atoms Ligands typically O(100) atoms predicted
More informationEarly Stages of Drug Discovery in the Pharmaceutical Industry
Early Stages of Drug Discovery in the Pharmaceutical Industry Daniel Seeliger / Jan Kriegl, Discovery Research, Boehringer Ingelheim September 29, 2016 Historical Drug Discovery From Accidential Discovery
More informationTowards Physics-based Models for ADME/Tox. Tyler Day
Towards Physics-based Models for ADME/Tox Tyler Day Overview Motivation Application: P450 Site of Metabolism Application: Membrane Permeability Future Directions and Applications Motivation Advantages
More informationPrinciples of Drug Design
Advanced Medicinal Chemistry II Principles of Drug Design Tentative Course Outline Instructors: Longqin Hu and John Kerrigan Direct questions and enquiries to the Course Coordinator: Longqin Hu I. Introduction
More informationUsing Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites. J. Andrew Surface
Using Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites Introduction J. Andrew Surface Hampden-Sydney College / Virginia Commonwealth University In the past several decades
More informationGyörgy M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences
Fragment based lead discovery - introduction György M. Keserű H2020 FRAGET etwork Hungarian Academy of Sciences www.fragnet.eu Hit discovery from screening Druglike library Fragment library Large molecules
More informationAdvanced in silico Drug Design KFC/ADD
Advanced in silico Drug Design S pozdravem KFC/ADD Molecular Karel Berka Docking Intro Karel Berka, Ph.D. Jindřich Fanfrlík, Ph.D. Martin Lepšík, Ph.D. Pavel Polishchuk, Ph.D. UP Olomouc, 30.1.-1.2. 2017
More informationPharmacophore Approaches In Drug Discovery
Pharmacophore Approaches In Drug Discovery Prof. Thierry Langer Prestwick Chemical, Inc. Boulevard Gonthier d Andernach 67400 Strasbourg-Illkirch, France Contents Introduction - Non HTS Hit Recognition
More informationThe Schrödinger KNIME extensions
The Schrödinger KNIME extensions Computational Chemistry and Cheminformatics in a workflow environment Jean-Christophe Mozziconacci Volker Eyrich Topics What are the Schrödinger extensions? Workflow application
More informationTRAINING REAXYS MEDICINAL CHEMISTRY
TRAINING REAXYS MEDICINAL CHEMISTRY 1 SITUATION: DRUG DISCOVERY Knowledge survey Therapeutic target Known ligands Generate chemistry ideas Chemistry Check chemical feasibility ELN DBs In-house Analyze
More informationNotes of Dr. Anil Mishra at 1
Introduction Quantitative Structure-Activity Relationships QSPR Quantitative Structure-Property Relationships What is? is a mathematical relationship between a biological activity of a molecular system
More informationAdvanced Medicinal Chemistry SLIDES B
Advanced Medicinal Chemistry Filippo Minutolo CFU 3 (21 hours) SLIDES B Drug likeness - ADME two contradictory physico-chemical parameters to balance: 1) aqueous solubility 2) lipid membrane permeability
More informationMachine Learning Concepts in Chemoinformatics
Machine Learning Concepts in Chemoinformatics Martin Vogt B-IT Life Science Informatics Rheinische Friedrich-Wilhelms-Universität Bonn BigChem Winter School 2017 25. October Data Mining in Chemoinformatics
More informationest Drive K20 GPUs! Experience The Acceleration Run Computational Chemistry Codes on Tesla K20 GPU today
est Drive K20 GPUs! Experience The Acceleration Run Computational Chemistry Codes on Tesla K20 GPU today Sign up for FREE GPU Test Drive on remotely hosted clusters www.nvidia.com/gputestd rive Shape Searching
More informationDifferent conformations of the drugs within the virtual library of FDA approved drugs will be generated.
Chapter 3 Molecular Modeling 3.1. Introduction In this study pharmacophore models will be created to screen a virtual library of FDA approved drugs for compounds that may inhibit MA-A and MA-B. The virtual
More informationStudying the effect of noise on Laplacian-modified Bayesian Analysis and Tanimoto Similarity
Studying the effect of noise on Laplacian-modified Bayesian nalysis and Tanimoto Similarity David Rogers, Ph.D. SciTegic, Inc. (Division of ccelrys, Inc.) drogers@scitegic.com Description of: nalysis methods
More informationUser Guide for LeDock
User Guide for LeDock Hongtao Zhao, PhD Email: htzhao@lephar.com Website: www.lephar.com Copyright 2017 Hongtao Zhao. All rights reserved. Introduction LeDock is flexible small-molecule docking software,
More informationDevelopment and application of ligand-based computational methods for de-novo drug. design and virtual screening. Alexander Richard Geanes.
Development and application of ligand-based computational methods for de-novo drug design and virtual screening By Alexander Richard Geanes Thesis Submitted to the Faculty of the Graduate School of Vanderbilt
More informationData Mining in the Chemical Industry. Overview of presentation
Data Mining in the Chemical Industry Glenn J. Myatt, Ph.D. Partner, Myatt & Johnson, Inc. glenn.myatt@gmail.com verview of presentation verview of the chemical industry Example of the pharmaceutical industry
More informationDrug Design 2. Oliver Kohlbacher. Winter 2009/ QSAR Part 4: Selected Chapters
Drug Design 2 Oliver Kohlbacher Winter 2009/2010 11. QSAR Part 4: Selected Chapters Abt. Simulation biologischer Systeme WSI/ZBIT, Eberhard-Karls-Universität Tübingen Overview GRIND GRid-INDependent Descriptors
More informationBioSolveIT. A Combinatorial Approach for Handling of Protonation and Tautomer Ambiguities in Docking Experiments
BioSolveIT Biology Problems Solved using Information Technology A Combinatorial Approach for andling of Protonation and Tautomer Ambiguities in Docking Experiments Ingo Dramburg BioSolve IT Gmb An der
More informationPing-Chiang Lyu. Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University.
Pharmacophore-based Drug design Ping-Chiang Lyu Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University 96/08/07 Outline Part I: Analysis The analytical
More informationAn Enhancement of Bayesian Inference Network for Ligand-Based Virtual Screening using Features Selection
American Journal of Applied Sciences 8 (4): 368-373, 2011 ISSN 1546-9239 2010 Science Publications An Enhancement of Bayesian Inference Network for Ligand-Based Virtual Screening using Features Selection
More informationKinome-wide Activity Models from Diverse High-Quality Datasets
Kinome-wide Activity Models from Diverse High-Quality Datasets Stephan C. Schürer*,1 and Steven M. Muskal 2 1 Department of Molecular and Cellular Pharmacology, Miller School of Medicine and Center for
More informationPrinciples of Drug Design
(16:663:502) Instructors: Longqin Hu and John Kerrigan Direct questions and enquiries to the Course Coordinator: Longqin Hu For more current information, please check WebCT at https://webct.rutgers.edu
More informationStructural interpretation of QSAR models a universal approach
Methods and Applications of Computational Chemistry - 5 Kharkiv, Ukraine, 1 5 July 2013 Structural interpretation of QSAR models a universal approach Victor Kuz min, Pavel Polishchuk, Anatoly Artemenko,
More informationAMRI COMPOUND LIBRARY CONSORTIUM: A NOVEL WAY TO FILL YOUR DRUG PIPELINE
AMRI COMPOUD LIBRARY COSORTIUM: A OVEL WAY TO FILL YOUR DRUG PIPELIE Muralikrishna Valluri, PhD & Douglas B. Kitchen, PhD Summary The creation of high-quality, innovative small molecule leads is a continual
More informationIntegrated Cheminformatics to Guide Drug Discovery
Integrated Cheminformatics to Guide Drug Discovery Matthew Segall, Ed Champness, Peter Hunt, Tamsin Mansley CINF Drug Discovery Cheminformatics Approaches August 23 rd 2017 Optibrium, StarDrop, Auto-Modeller,
More informationOctober 6 University Faculty of pharmacy Computer Aided Drug Design Unit
October 6 University Faculty of pharmacy Computer Aided Drug Design Unit CADD@O6U.edu.eg CADD Computer-Aided Drug Design Unit The development of new drugs is no longer a process of trial and error or strokes
More informationConformational Sampling of Druglike Molecules with MOE and Catalyst: Implications for Pharmacophore Modeling and Virtual Screening
J. Chem. Inf. Model. 2008, 48, 1773 1791 1773 Conformational Sampling of Druglike Molecules with MOE and Catalyst: Implications for Pharmacophore Modeling and Virtual Screening I-Jen Chen* and Nicolas
More informationPerforming a Pharmacophore Search using CSD-CrossMiner
Table of Contents Introduction... 2 CSD-CrossMiner Terminology... 2 Overview of CSD-CrossMiner... 3 Searching with a Pharmacophore... 4 Performing a Pharmacophore Search using CSD-CrossMiner Version 2.0
More information5.1. Hardwares, Softwares and Web server used in Molecular modeling
5. EXPERIMENTAL The tools, techniques and procedures/methods used for carrying out research work reported in this thesis have been described as follows: 5.1. Hardwares, Softwares and Web server used in
More informationA COMPARATIVE STUDY OF MACHINE-LEARNING-BASED SCORING FUNCTIONS IN PREDICTING PROTEIN-LIGAND BINDING AFFINITY. Hossam Mohamed Farg Ashtawy A THESIS
A COMPARATIVE STUDY OF MACHINE-LEARNING-BASED SCORING FUNCTIONS IN PREDICTING PROTEIN-LIGAND BINDING AFFINITY By Hossam Mohamed Farg Ashtawy A THESIS Submitted to Michigan State University in partial fulfillment
More informationDrug Informatics for Chemical Genomics...
Drug Informatics for Chemical Genomics... An Overview First Annual ChemGen IGERT Retreat Sept 2005 Drug Informatics for Chemical Genomics... p. Topics ChemGen Informatics The ChemMine Project Library Comparison
More informationMD Simulation in Pose Refinement and Scoring Using AMBER Workflows
MD Simulation in Pose Refinement and Scoring Using AMBER Workflows Yuan Hu (On behalf of Merck D3R Team) D3R Grand Challenge 2 Webinar Department of Chemistry, Modeling & Informatics Merck Research Laboratories,
More information11. IN SILICO DOCKING ANALYSIS
11. IN SILICO DOCKING ANALYSIS 11.1 Molecular docking studies of major active constituents of ethanolic extract of GP The major active constituents are identified from the ethanolic extract of Glycosmis
More informationUniversities of Leeds, Sheffield and York
promoting access to White Rose research papers Universities of Leeds, Sheffield and York http://eprints.whiterose.ac.uk/ This is an author produced version of a paper published in Organic & Biomolecular
More information